TDR, the Special Programme for Research and Training in Tropical Diseases
A three-finger pinch of salt, a fistful of gur – a sort of unrefined sugar or molasses – in half a litre of water; this simple concoction revolutionized the treatment of diarrhoea in Bangladeshi children in the 1980s. Oral rehydration therapy (ORT), in its various guises, has since become a major tool in the … Continue reading Chowdhury champions constant learning, evaluation and innovation in research
TropIKA.net Last month, the European Union (EU) published its largest ever call for proposals to fund research, amounting to over €6 billion (US$7.9bn). The funding for 2011 health research projects draws on the €53 billion budget of the Seventh Framework Programme for research and technological development (FP7), the EU’s chief instrument for funding research over … Continue reading EU research funding: a mixed blessing for global health scientists
If all goes well, the first malaria drug developed by Thai researchers could reach human clinical trials at the beginning of next year. The drug, dubbed P218, is the product of research carried out by a group at BIOTEC, a research centre created by the Thai government to generate biotechnology innovations. Although several international partners, … Continue reading BIOTEC leads Thailand’s leapfrog towards self-sufficiency
Peter Ndumbe was working in London when the new HIV virus began to emerge in the early eighties. One of the multitude of scientists trying to understand the pathogen, he focused on hepatitis and its possible links to the new virus See the rest of the story here.
17 March 2010A collaboration, called the Open Source Drug Discovery Foundation (OSDD), plans to use voluntary and open efforts to accelerate the development of affordable drugs for diseases including malaria, leishmaniasis and – first – tuberculosis. Few if any new drugs have been created for many of these diseases, because they disproportionately affect the poor … Continue reading Open source: the way forward in the search for new treatments for the infectious diseases of poverty?